Table of Contents
Chemotherapy Research and Practice
Volume 2012, Article ID 743193, 7 pages
http://dx.doi.org/10.1155/2012/743193
Review Article

The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

1Department of Internal Medicine, Emory University, Atlanta, GA 30322, USA
2Department of Hematology & Medical Oncology, Emory University, Atlanta, GA 30322, USA
3Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA

Received 10 June 2012; Accepted 26 November 2012

Academic Editor: Nabil F. Saba

Copyright © 2012 Zahi Mitri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Zahi Mitri, Tina Constantine, and Ruth O'Regan, “The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy,” Chemotherapy Research and Practice, vol. 2012, Article ID 743193, 7 pages, 2012. https://doi.org/10.1155/2012/743193.